Home › Oral Cancer › Iowa › Ames
Oral Cancer clinical trials in Ames, IA
3 studies for Oral Cancer are looking for participants at sites in and around Ames (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- McFarland Clinic - Ames, Ames
About Oral Cancer
Oral cancer can form in the mouth or throat but usually begins in the tongue and floor of the mouth. Read about the common oral cancer symptoms.
More about Oral Cancer on MedlinePlus
Oral Cancer trials in other cities
- Atlanta, GA9 studies
- St. Louis, MO8 studies
- Chicago, IL8 studies
- New York City, NY8 studies
- Durham, NC7 studies
- Houston, TX7 studies
- Milwaukee, WI7 studies
- Pittsburgh, PA7 studies
- Kansas City, MO7 studies
- Portland, OR7 studies
- Ann Arbor, MI7 studies
- Richmond, VA7 studies
Other studies in Ames
- Prostate Cancer7 studies
- Lung Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Breast Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Bladder Cancer4 studies
- Chronic Lymphocytic Leukemia3 studies
- Hypopharyngeal Cancer3 studies
- Laryngeal Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.